Wasatch Advisors Inc increased Chemocentryx Inc (CCXI) stake by 6.08% reported in 2019Q1 SEC filing. Wasatch Advisors Inc acquired 141,341 shares as Chemocentryx Inc (CCXI)’s stock declined 38.33%. The Wasatch Advisors Inc holds 2.46 million shares with $34.23M value, up from 2.32M last quarter. Chemocentryx Inc now has $382.70 million valuation. The stock decreased 3.52% or $0.24 during the last trading session, reaching $6.57. About 453,549 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has declined 28.17% since August 15, 2018 and is downtrending. It has underperformed by 28.17% the S&P500. Some Historical CCXI News: 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 ChemoCentryx 4Q EPS 80c; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/03/2018 – ChemoCentryx 4Q Net $39.7M
Hsbc Holdings Plc decreased Advanced Micro Devices Inc (AMD) stake by 48.85% reported in 2019Q1 SEC filing. Hsbc Holdings Plc sold 534,249 shares as Advanced Micro Devices Inc (AMD)’s stock rose 13.58%. The Hsbc Holdings Plc holds 559,360 shares with $14.28 million value, down from 1.09 million last quarter. Advanced Micro Devices Inc now has $32.57B valuation. The stock decreased 0.78% or $0.24 during the last trading session, reaching $30. About 32.52M shares traded. Advanced Micro Devices, Inc. (NASDAQ:AMD) has risen 56.80% since August 15, 2018 and is uptrending. It has outperformed by 56.80% the S&P500. Some Historical AMD News: 27/04/2018 – BIOPHYTIS SA ALBPS.PA – MACUNEOS IS THE ONLY DRUG CANDIDATE IN CLINICAL DEVELOPMENT TO TREAT DRY AMD; 05/03/2018 – AUTOMODULAR – AMD CURRENTLY BELIEVES SETTLEMENT PROCEEDS IN RESPECT OF GM CLAIM MAY NOT BE RECEIVED FROM GENERAL MOTORS ON OR BEFORE MARCH 7, 2018; 26/04/2018 – Cramer says Advanced Micro Devices is a buy, but Whirlpool is a sell; 21/04/2018 – DJ Advanced Micro Devices Inc, Inst Holders, 1Q 2018 (AMD); 20/03/2018 – ADVANCED MICRO DEVICES – SECURITY ISSUES IDENTIFIED BY THIRD-PARTY RESEARCHERS ARE NOT RELATED TO AMD “ZEN” CPU ARCHITECTURE; 26/04/2018 – Dow rises about 200 points, Facebook and AMD jump after crushing earnings; 29/03/2018 – Fudzilla: AMD’s open-source Radeon Rays integrated into Unity engine; 25/04/2018 – AMD: Cryptocurrency-related Revenue Rose In First Quarter, But Headed For Decline — MarketWatch; 15/03/2018 – AMD Propels Tear-Free Gameplay Beyond the PC with Support for Radeon FreeSync™ Technology in Select Xbox One Consoles; 13/03/2018 – ADVANCED MICRO DEVICES – INVESTIGATING CTS LABS REPORT, WHICH CO GOT, TO UNDERSTAND METHODOLOGY & MERIT OF FINDINGS
Investors sentiment increased to 1.52 in 2019 Q1. Its up 0.21, from 1.31 in 2018Q4. It is positive, as 43 investors sold AMD shares while 129 reduced holdings. 102 funds opened positions while 159 raised stakes. 634.98 million shares or 5.37% more from 602.61 million shares in 2018Q4 were reported. Cornerstone Advisors invested 0% of its portfolio in Advanced Micro Devices, Inc. (NASDAQ:AMD). M&R has 480 shares. State Of New Jersey Common Pension Fund D holds 600,000 shares or 0.06% of its portfolio. Citigroup holds 0.01% or 284,368 shares. Stifel Corporation owns 243,987 shares or 0.02% of their US portfolio. Jaffetilchin Lc accumulated 11,433 shares. Jennison Ltd Limited Liability Company, New York-based fund reported 786,485 shares. Trust Of Vermont reported 78 shares stake. Wetherby Asset invested 0.05% in Advanced Micro Devices, Inc. (NASDAQ:AMD). Fred Alger Mgmt Inc holds 0.04% or 351,372 shares in its portfolio. Bb&T Ltd Liability Corporation holds 44,710 shares or 0.01% of its portfolio. Tci Wealth Advsr holds 0.03% of its portfolio in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 2,348 shares. Commerce Bank reported 0.01% stake. Envestnet Asset Mngmt Inc has 18,771 shares. Baystate Wealth Mgmt Limited Liability Company holds 0% of its portfolio in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 45 shares.
Hsbc Holdings Plc increased Abbott Labs (Put) (NYSE:ABT) stake by 173,600 shares to 297,100 valued at $23.75 million in 2019Q1. It also upped Ecolab Inc (Put) (NYSE:ECL) stake by 9,700 shares and now owns 14,700 shares. 3M Co (Call) (NYSE:MMM) was raised too.
Among 8 analysts covering Advanced Micro Devices (NASDAQ:AMD), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Advanced Micro Devices has $42 highest and $1700 lowest target. $33.22’s average target is 10.73% above currents $30 stock price. Advanced Micro Devices had 22 analyst reports since March 13, 2019 according to SRatingsIntel. The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) earned “Buy” rating by RBC Capital Markets on Wednesday, March 13. The firm has “Sell” rating by Morgan Stanley given on Monday, March 25. The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) has “Buy” rating given on Monday, April 8 by Bank of America. The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) has “Sell” rating given on Tuesday, March 19 by Morgan Stanley. Jefferies maintained the shares of AMD in report on Wednesday, March 20 with “Buy” rating. The firm has “Buy” rating given on Friday, June 21 by Wells Fargo. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, July 31. The company was maintained on Wednesday, March 20 by Rosenblatt.
More notable recent Advanced Micro Devices, Inc. (NASDAQ:AMD) news were published by: Seekingalpha.com which released: “AMD: High Ground Vs. Low Ground – Seeking Alpha” on August 15, 2019, also Nasdaq.com with their article: “Why Advanced Micro Devices Stock Rocketed Higher Today – Nasdaq” published on August 08, 2019, Seekingalpha.com published: “AMD target boosted for product execution – Seeking Alpha” on August 12, 2019. More interesting news about Advanced Micro Devices, Inc. (NASDAQ:AMD) were released by: Nasdaq.com and their article: “Advanced Micro Devices (AMD) 2nd Quarter Earnings: What to Expect – Nasdaq” published on July 30, 2019 as well as Benzinga.com‘s news article titled: “Crazy Action In AMD Options As Traders Take Sides In Volatile Market – Benzinga” with publication date: August 14, 2019.
Wasatch Advisors Inc decreased Zagg Inc (NASDAQ:ZAGG) stake by 208,853 shares to 1.27M valued at $11.56 million in 2019Q1. It also reduced Euronet Worldwide Inc (NASDAQ:EEFT) stake by 218,656 shares and now owns 2.39M shares. Aaon Inc (NASDAQ:AAON) was reduced too.
Investors sentiment increased to 1.44 in Q1 2019. Its up 0.51, from 0.93 in 2018Q4. It is positive, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. Northern Tru Corporation has 310,007 shares for 0% of their portfolio. Wasatch owns 0.37% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 2.46 million shares. Zebra Cap Ltd Company invested in 12,853 shares. National Bank Of New York Mellon has 133,619 shares for 0% of their portfolio. Clarivest Asset Management Limited Co invested in 0.01% or 51,400 shares. Citigroup reported 6,829 shares stake. 132,410 are owned by Marshall Wace Llp. Sio Capital Management Limited owns 530,175 shares. Baker Bros Advsr Limited Partnership reported 207,029 shares stake. Ameriprise Financial holds 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 261,396 shares. Invesco Limited, a Georgia-based fund reported 148,988 shares. Dorsey Wright Assocs holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 585 shares. 55,800 were reported by Strs Ohio. Jacobs Levy Equity Mgmt Inc stated it has 51,190 shares. Employees Retirement Systems Of Ohio holds 99,284 shares or 0.01% of its portfolio.
Among 2 analysts covering ChemoCentryx (NASDAQ:CCXI), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx has $2400 highest and $22 lowest target. $23’s average target is 250.08% above currents $6.57 stock price. ChemoCentryx had 4 analyst reports since March 12, 2019 according to SRatingsIntel. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) earned “Buy” rating by FBR Capital on Wednesday, March 27. The company was maintained on Tuesday, March 12 by H.C. Wainwright.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “ChemoCentryx (CCXI) Reports Q2 Loss, Lags Revenue Estimates – Nasdaq” on August 05, 2019, also Seekingalpha.com with their article: “ChemoCentryx down 16% after Q2 revenue miss – Seeking Alpha” published on August 06, 2019, Finance.Yahoo.com published: “ChemoCentryx Inc (CCXI) Q2 2019 Earnings Call Transcript – Yahoo Finance” on August 08, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Nasdaq.com and their article: “ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019 – Nasdaq” published on July 31, 2019 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx, Inc. 2019 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: August 06, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.